TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma	B7-H3-positive Relapsed/ Refractory Neuroblastoma	Recruiting	Phase 1	2023-02-27		NCT05562024

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
PersonGen BioTherapeutics (Suzhou) Co., Ltd.	13
Shandong Cancer Hospital and Institute	71
Tianjin Medical University Cancer Institute and Hospital	287

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shandong cancer hospital and institute	Jinan	China	3
Tianjin Medical University Cancer Institute and Hospital	Tianjin	China	13

Clinical trials